![Medicine / Isoxazoles / Analgesics / Valdecoxib / Pfizer / Stevens–Johnson syndrome / Toxic epidermal necrolysis / Postmarketing surveillance / Erythroderma / Sulfonamides / Drug eruptions / Health Medicine / Isoxazoles / Analgesics / Valdecoxib / Pfizer / Stevens–Johnson syndrome / Toxic epidermal necrolysis / Postmarketing surveillance / Erythroderma / Sulfonamides / Drug eruptions / Health](https://www.pdfsearch.io/img/57e952d7f71b8f7087b42142a5680340.jpg)
| Open Document File Size: 466,67 KBShare Result on Facebook
City New York / North Peapack / / Company Pfizer / Pain Global Medical Affairs Pharmacia Corporation / Pharmacia Corporation / Worldwide Team Pfizer Inc / / Event FDA Phase / / / IndustryTerm healthcare professionals / / MedicalCondition Stevens-Johnson syndrome / adult rheumatoid arthritis / osteoarthritis / Medical Director Arthritis / angioedema / erythema multiforme / anaphylactic reactions / hypersensitivity / skin rash / toxic epidermal necrolysis / exfoliative dermatitis / / Organization FDA / / Person Mona M. Wahba / James B. Jones / / / Position Director Arthritis / Medical Director / / Product BEXTRA / BEXTRA® (valdecoxib tablets) / / ProvinceOrState New Jersey / New York / / URL www.accessdata.fda.gov/scripts/medwatch / /
SocialTag |